TEPLIZUMAB (tep LIZ oo mab) delays the onset of type 1 diabetes (T1D). It may also slow the decline in insulin made by the body in people recently diagnosed with T1D. It works by slowing down an overactive immune system. It is a monoclonal antibody.


There is no lifestyle interaction information available for this medication.